Panagora Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Panagora Asset Management’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,977	Closed	-$447K	–	1524
2022 Q3	$447K	Buy	1,977 +16	+0.8%	+$3.93K	﹤0.01%	1172
2022 Q2	$371K	Sell	1,961 -23	-1%	-$4.64K	﹤0.01%	1254
2022 Q1	$494K	Hold	1,984	–	–	﹤0.01%	1213
2021 Q4	$309K	Buy	1,984 +1,229	+163%	+$238K	﹤0.01%	1366
2021 Q3	$151K	Buy	755 +732	+3,183%	+$174K	﹤0.01%	1669
2021 Q2	$6K	Buy	+23	New	+$5.74K	﹤0.01%	2455
2015 Q4	–	Sell	-544	Closed	-$257K	–	2380
2015 Q3	$257K	Buy	544 +169	+45%	+$89.6K	﹤0.01%	1533
2015 Q2	$213K	Buy	375 +303	+421%	+$839K	﹤0.01%	1643
2015 Q1	$618K	Buy	+72	New	+$629K	﹤0.01%	1236

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Panagora Asset Management's EIGR Position: Q4 2022 in Review

Panagora Asset Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q4 2022, closing a stake of 1,977 shares — an estimated $447K sold.

Panagora Asset Management first reported a position in EIGR in Q1 2015 and held it in 9 quarters. The position peaked at $618K in Q1 2015. 81 funds tracked by Wall St. Rank hold EIGR as of Q4 2022.

Panagora Asset Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Panagora Asset Management sold 1,977 Eiger BioPharmaceuticals, Inc. shares in Q4 2022, an estimated $447K.
Panagora Asset Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 9 quarters.
Panagora Asset Management's Eiger BioPharmaceuticals, Inc. position peaked at $618K in Q1 2015.
81 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2022.

Based on Panagora Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.